FI965144A - Sterolderivat för användning för regulering av meios - Google Patents

Sterolderivat för användning för regulering av meios Download PDF

Info

Publication number
FI965144A
FI965144A FI965144A FI965144A FI965144A FI 965144 A FI965144 A FI 965144A FI 965144 A FI965144 A FI 965144A FI 965144 A FI965144 A FI 965144A FI 965144 A FI965144 A FI 965144A
Authority
FI
Finland
Prior art keywords
meiosis
regulation
sterol derivatives
derivatives
sterol
Prior art date
Application number
FI965144A
Other languages
English (en)
Finnish (fi)
Other versions
FI965144A0 (sv
FI117159B (sv
Inventor
Anne Grete Byskov
Claus Yding Andersen
Lars Nordholm
Henning Thoegersen
Ole Wassmann
Ivan Verner Diers
Erling Guddal
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI965144A0 publication Critical patent/FI965144A0/sv
Publication of FI965144A publication Critical patent/FI965144A/sv
Application granted granted Critical
Publication of FI117159B publication Critical patent/FI117159B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI965144A 1994-06-23 1996-12-20 Sterolderivat, som användes för reglering av meiosis FI117159B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK75394 1994-06-23
DK24195 1995-03-09
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis
DK9500265 1995-06-23

Publications (3)

Publication Number Publication Date
FI965144A0 FI965144A0 (sv) 1996-12-20
FI965144A true FI965144A (sv) 1997-02-20
FI117159B FI117159B (sv) 2006-07-14

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965144A FI117159B (sv) 1994-06-23 1996-12-20 Sterolderivat, som användes för reglering av meiosis

Country Status (26)

Country Link
US (1) US5716777A (sv)
EP (1) EP0767798B1 (sv)
JP (1) JP3987105B2 (sv)
KR (1) KR100408369B1 (sv)
CN (1) CN1068333C (sv)
AT (1) ATE248852T1 (sv)
AU (1) AU694240B2 (sv)
BG (1) BG101067A (sv)
BR (1) BR9508074A (sv)
CA (1) CA2192941C (sv)
CZ (1) CZ289407B6 (sv)
DE (1) DE69531682T2 (sv)
DK (1) DK0767798T3 (sv)
ES (1) ES2204955T3 (sv)
FI (1) FI117159B (sv)
HU (1) HUT76343A (sv)
IL (1) IL114294A (sv)
IS (1) IS4404A (sv)
MX (1) MX9700174A (sv)
NO (1) NO314534B1 (sv)
PL (1) PL186688B1 (sv)
RU (1) RU2194510C2 (sv)
SI (1) SI9520077A (sv)
SK (1) SK165596A3 (sv)
UA (1) UA51622C2 (sv)
WO (1) WO1996000235A1 (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996027658A1 (en) * 1995-03-06 1996-09-12 Novo Nordisk A/S Stimulation of meiosis
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
CN1191543A (zh) * 1995-06-23 1998-08-26 诺沃挪第克公司 减数分裂调控化合物
ATE238339T1 (de) * 1996-12-20 2003-05-15 Novo Nordisk As Verbindungen zur regulierung der meiose
CN1260802A (zh) * 1997-05-16 2000-07-19 阿克佐诺贝尔公司 20－芳烷基－5α－孕甾烷衍生物
TR199902873T2 (xx) * 1997-06-04 2000-04-21 Akzo Nobel N.V. Miyozun mod�lasyonu i�in 17�-aliloksi(tiyo)alkil-androstan t�revleri.
EP1042353B1 (en) 1997-12-18 2002-07-17 Akzo Nobel N.V. 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives
KR20010043558A (ko) 1998-05-13 2001-05-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열 조절 화합물
PL344155A1 (en) * 1998-05-13 2001-10-08 Novo Nordisk As Meiosis regulating compounds
CA2333320A1 (en) * 1998-05-26 1999-12-02 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
EP1087988A1 (en) * 1998-06-19 2001-04-04 Novo Nordisk A/S Meiosis regulating compounds
DE69903346T2 (de) * 1998-12-11 2003-01-30 Akzo Nobel N.V., Arnheim/Arnhem 22s-hydroxycholesta-8,14-dien derivate mit meiose regulierende aktivität
WO2000036132A1 (en) 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
WO2000047604A1 (en) * 1999-02-10 2000-08-17 Schering Aktiengesellschaft Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
ES2258445T3 (es) 1999-02-24 2006-09-01 Novo Nordisk A/S Metodo in vitro para la sincronizacion de la maduracion de ovocitos.
ATE361091T1 (de) * 1999-02-24 2007-05-15 Novo Nordisk As Behandlung von unfruchtbarkeit
WO2000052142A2 (en) * 1999-02-26 2000-09-08 Novo Nordisk A/S Culture medium comprising meiosis activating sterols (mas) and method for in vitro fertilisation
EP1163258B1 (en) * 1999-03-09 2002-12-11 Akzo Nobel N.V. 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
AU781994B2 (en) * 1999-09-16 2005-06-23 Novo Nordisk A/S Composition for IVF
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
WO2001062260A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
WO2001062258A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate using ff-mas
MXPA02011271A (es) * 2000-05-18 2003-04-25 Schering Ag Fertilizacion de oocitos envejecidos.
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
AU2003203145A1 (en) * 2002-02-22 2003-09-09 Novo Nordisk A/S A transducer of mas signalling
WO2012044817A2 (en) * 2010-10-01 2012-04-05 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
CZ372596A3 (en) 1997-07-16
IL114294A (en) 2002-09-12
HU9603584D0 (en) 1997-02-28
PL317830A1 (en) 1997-04-28
MX9700174A (es) 1997-04-30
KR100408369B1 (ko) 2004-04-28
EP0767798B1 (en) 2003-09-03
NO965516L (no) 1997-02-21
HUT76343A (en) 1997-08-28
CA2192941A1 (en) 1996-01-04
DE69531682T2 (de) 2004-07-15
UA51622C2 (uk) 2002-12-16
FI965144A0 (sv) 1996-12-20
DK0767798T3 (da) 2003-12-22
AU694240B2 (en) 1998-07-16
US5716777A (en) 1998-02-10
SI9520077A (sl) 1998-06-30
IS4404A (is) 1996-12-23
SK165596A3 (en) 1997-08-06
ES2204955T3 (es) 2004-05-01
DE69531682D1 (de) 2003-10-09
NO314534B1 (no) 2003-04-07
EP0767798A1 (en) 1997-04-16
PL186688B1 (pl) 2004-02-27
CA2192941C (en) 2009-04-14
CN1151164A (zh) 1997-06-04
FI117159B (sv) 2006-07-14
BR9508074A (pt) 1997-08-12
NO965516D0 (no) 1996-12-20
ATE248852T1 (de) 2003-09-15
CN1068333C (zh) 2001-07-11
WO1996000235A1 (en) 1996-01-04
JP3987105B2 (ja) 2007-10-03
AU2734395A (en) 1996-01-19
RU2194510C2 (ru) 2002-12-20
JPH10502060A (ja) 1998-02-24
IL114294A0 (en) 1995-10-31
CZ289407B6 (cs) 2002-01-16
BG101067A (en) 1997-08-29

Similar Documents

Publication Publication Date Title
FI965144A0 (sv) Sterolderivat för användning för regulering av meios
BG104247A (en) Resorcinol derivatives
IT1285770B1 (it) Composti corticoidei
FI972387A (sv) Dermalt applicerbara parasiticidkompositioner
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
ATE126215T1 (de) Anti-entzündende 4-aminophenol-derivate.
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
NO955141L (no) Reguleringsanordning for stol
ATE203519T1 (de) Chinolinderivate als antimalariamittel
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
NO965444D0 (no) Triterpen-derivat samt medikamentell sammensetning omfattende dette
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
SE9801494D0 (sv) Novel use
PL323235A1 (en) Derivatives of piperazine as neurokinin antagonists
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
SE9504662D0 (sv) New compounds
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
DK0967986T3 (da) Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat
TR199800705T2 (sv)
FI940088A0 (fi) Regleranordning/reglerdel foer spolvattenmnaengden i en vattenklosett

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117159

Country of ref document: FI